United States, Oklahoma — Oklahoma City, Oklahoma

United States, Oklahoma is a clinical research site located in Oklahoma City, Oklahoma, United States 73131.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

United States, Oklahoma has participated in 4 clinical trials.

Therapeutic areas: Includes: Hereditary Angioedema, Epilepsy, Crohn's Disease.

Sponsors: CSL Behring, UCB Biopharma S.P.R.L., Otsuka Pharmaceutical Development & Commercialization, Inc..

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for United States, Oklahoma?

United States, Oklahoma has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has United States, Oklahoma conducted?

United States, Oklahoma has 4 clinical trials on record. Their work covers Includes: Hereditary Angioedema, Epilepsy, Crohn's Disease.

Is United States, Oklahoma accredited by Crixeo Health?

United States, Oklahoma has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about United States, Oklahoma?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.